AOD-9604 is a synthetic peptide fragment developed to isolate and enhance one of the most sought-after physiological effects of human growth hormone (hGH): fat metabolism. As a modified version of the C-terminal region of hGH, AOD-9604 retains the ability to influence adipose tissue breakdown without triggering the growth-promoting or insulin-like effects typically associated with full-length GH administration (Rogol et al.).
Its design makes it especially relevant in the context of non-proliferative metabolic studies, particularly those focused on lipolysis, energy expenditure, tissue remodeling, and fat redistribution (Schänzer & Thevis). Because AOD-9604 does not significantly affect IGF-1 levels or glucose regulation, it offers researchers a more targeted tool for investigating fat metabolism without disrupting broader endocrine pathways.
This blog explores what AOD-9604 is, how it functions, and why it continues to be studied in models of metabolic regulation, connective tissue support, and selective adipose modulation.
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone, specifically representing amino acids 176–191 of the hGH sequence. This portion of the GH molecule was selected because it appears to be responsible for fat-reducing effects, distinct from the growth- and glucose-related effects of the hormone as a whole (Mancini & Halpern).
Unlike full-length GH, which affects a wide range of physiological systems, including muscle growth, bone development, and insulin signaling, AOD-9604 was engineered to act selectively on fat tissue, making it an ideal candidate for studies where lipid metabolism is the primary focus (Thevis & Schänzer).
This selective action profile, combined with the absence of IGF-1 stimulation, has made AOD-9604 particularly valuable in experimental settings where researchers want to isolate and analyze the fat-modulatory effects of GH-derived peptides without introducing the broader systemic effects of recombinant hGH or secretagogue therapies. Because of this, AOD-9604 is frequently used in preclinical research exploring obesity, body composition management, and tissue remodeling pathways.
The mechanism of action of AOD-9604 is notably distinct from that of native GH or other GH secretagogues. Rather than binding to the classical GH receptor or triggering the release of endogenous GH, AOD-9604 appears to function via receptor-independent pathways related to lipid metabolism.
Current research suggests that AOD-9604 works by:
A key benefit of AOD-9604 in research is that it does not raise IGF-1 levels, avoiding one of the most common confounding variables in GH research (Kos et al.). It also has minimal effects on insulin and glucose regulation, making it suitable for metabolic studies where researchers want to evaluate lipid dynamics without endocrine disruption.
Additionally, AOD-9604 has demonstrated tissue selectivity, which may allow for site-specific fat reduction or targeted metabolic outcomes without affecting lean tissue or bone turnover (Glykofrydi et al.). This property has made it a focus of studies on visceral fat reduction, fat redistribution, and metabolically healthy obesity models.
AOD-9604 has been explored across multiple fields of experimental biology due to its unique metabolic selectivity and lack of proliferative effects. It offers a compelling model for researchers studying how isolated peptide fragments can influence fat mass, recovery, and tissue remodeling without the complications of full-spectrum hormone therapy (Misra et al.; Liao et al.).
Research suggests that AOD-9604 may help reduce both subcutaneous and visceral fat in various animal models. This has led to its use in preclinical studies on obesity, body composition management, and metabolic syndrome, especially where selective fat reduction without lean mass loss is desired (Cheetham et al.; Mayer et al.; Correia & Haynes).
Although it doesn’t raise systemic GH or IGF-1 levels, AOD-9604 may positively affect energy expenditure and lipid oxidation, making it a relevant tool in studies investigating fat-burning pathways independent of traditional anabolic signaling.
Emerging research indicates that AOD-9604 may contribute to chondrocyte activity and cartilage preservation, opening up new areas of interest in orthopedic research, particularly in osteoarthritis and joint health models (Liao et al.).
By modulating fat metabolism and possibly influencing local tissue repair responses, AOD-9604 is being evaluated in contexts involving post-injury recovery, aesthetic fat distribution, and non-anabolic regenerative signaling (Liao et al.).
Together, these potential effects make AOD-9604 a useful peptide for exploring targeted metabolic modulation, particularly in studies focused on precision intervention without generalized endocrine stimulation.
|
Peptide |
Origin & Type |
Mechanism of Action |
Effect on GH/IGF-1 |
Primary Research Focus |
Distinctive Feature |
|
Modified fragment (176–191) of hGH |
Stimulates lipolysis and inhibits lipogenesis via non-GH receptor pathways |
No significant increase |
Adipose tissue metabolism, joint health, tissue remodeling |
Fat-selective action without systemic GH stimulation (Ng et al.) |
|
|
Synthetic GHRH analog |
Stimulates endogenous GH release via pituitary GHRH receptor binding |
Increases GH and IGF-1 |
GH pulsatility, aging, recovery, endocrine rhythm studies |
Long-acting GH stimulator with preserved feedback (Teichman et al.) |
|
|
Stabilized GHRH analog with lipid tail |
Prolonged stimulation of GH release through extended GHRH receptor activation |
Increases GH and IGF-1 |
Visceral fat reduction, HIV-associated lipodystrophy, metabolism (Stanley et al.) |
Targeted visceral fat reduction via extended GH stimulation |
Unlike full-length human growth hormone, which affects a wide variety of physiological processes, from musculoskeletal growth to glycemic regulation, AOD-9604 acts with a more targeted focus. Its primary mechanism influences adipose tissue rather than stimulating whole-body growth or systemic hormonal cascades.
This contrasts with peptides like:
Compared to these peptides, AOD-9604 does not act through the GH receptor or stimulate endogenous GH production, making it ideal for research where fat-specific outcomes are needed without the systemic influence of growth hormone elevation.
For laboratories focused on fat metabolism, tissue remodeling, or regenerative peptide signaling, access to high-purity research materials is essential. Polaris Peptides provides AOD-9604 that meets stringent quality standards, ensuring purity, stability, and reproducibility in non-clinical research settings.
Every batch is carefully tested and packaged to support advanced investigations into lipid signaling, energy dynamics, and selective fat modulation.
AOD-9604 represents a unique advancement in peptide research – offering the ability to influence fat metabolism without engaging in full-spectrum growth hormone activity. By isolating the fat-reducing region of hGH, it provides researchers with a tool for studying adipose regulation, energy balance, and tissue repair in a highly selective and controlled manner.
Its independence from IGF-1 and minimal effect on glucose metabolism makes it particularly attractive in studies that require targeted intervention without broader endocrine disruption. Whether in models of obesity, joint health, or tissue remodeling, AOD-9604 continues to demonstrate value as a precision peptide within the expanding field of growth hormone–derived compounds.
For those exploring these research domains, Polaris Peptides offers reliable access to high-quality AOD-9604, enabling scientific progress through rigorous, reproducible peptide investigation.
Discount Applied Successfully!
Your savings have been added to the cart.
Join our Polaris Insiders program to get rewarded for loyalty with exclusive deals, news about upcoming products, and more.
You must be 21 years old or older in order to access our website. Please verify your age.
Our products are crafted for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use. The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease.